Hepatitis B virus infection seromarkers among college freshmen and their immune responses to different vaccination policies of hepatitis B vaccine

References

• Sha HY, Du L, Wen L, Li SL. Epidemic dynamics and research progress of hepatitis B. J Prev Med Chin People Liberation Army. 2017;35(9):1149–53.
   Google Scholar
• World Health Organization. Global hepatitis report 2017. Geneva, Switzerland: WHO; 2017. p. 83.
   Google Scholar
• Qiao YL. Strategies and prospects of cancer population prevention and control in China. Chin J Oncol. 2012;34:483–85.
   Google Scholar
• Cui F, Shen L, Li L, Wang H, Wang F, Bi S, Liu J, Zhang G, Wang F, Zheng H, et al. Prevention of chronic hepatitis B after 3 decades of escalating vaccination policy, China. Emerg Infect Dis. 2017;23(5):765–72. doi:10.3201/eid2305.161477.
   PubMed Web of Science ®Google Scholar
• Chen HY, Li X, Peng SX. Impact of chronic hepatitis B and HBeAg status on maternal and infant outcomes. Chin J Dis Control Prev. 2018;22(6):617–20.
   Google Scholar
• Cui FQ, Gong XH, Chen YS, Wang F, Zheng W, Wu Z. Vaccination progress of hepatitis b vaccine and epidemiology changes of carrying rate of hepatitis B surface antigen by province in China, 1992–2006. Chin J Vaccines Immunization. 2012;18(1):6–13.
   Google Scholar
• Wang GQ, Wang FS, Chen J, Ren H, Zhuang H, Sun J, Li LJ, Li J, Meng QH, Zhao JM, et al. The guideline of prevention and treatment for chronic hepatitis B: a 2015 update. J Clin Hepatol. 2015;31(12):1941–60.
   Google Scholar
• Zhao YL, Han BH, Zhang XJ, Pan -L-L, Zhou H-S, Gao Z, Hao Z-Y, Wu Z-W, Ma T-L, Wang F, et al. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination. BMC Infect Dis. 2019;19(1):482. doi:10.1186/s12879-019-4134-9.
   PubMedGoogle Scholar
• Shen L, Wang F, Wang F, Cui F, Zhang S, Zheng H, Zhang Y, Liang X, Bi S. Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in China. Vaccine. 2012;30(47):6623–27. doi:10.1016/j.vaccine.2012.08.067.
   PubMed Web of Science ®Google Scholar
• Cui FQ, Zhuang H. Epidemics and control of hepatitis B in China . Chin J Viral Dis. 2018;8:257–64.
   Google Scholar
• Wu TW, Lin HH, Wang LY. Chronic hepatitis B infection in adolescents who received primary infantile vaccination. Hepatology. 2013;57(1):37–45. doi:10.1002/hep.25988.
   PubMed Web of Science ®Google Scholar
• Wang ZY, Dai DF, Xiao JH. Monitoring study of hepatitis B antibodies in healthy population and immune successful rate of hepatitis B vaccine in infants in Hunan . Pract Prev Med. 2010;17(5):888–89.
   Google Scholar
• Ni YH, Chang MH, Wu JF, Hsu H-Y, Chen H-L, Chen D-S. Minimization of hepatitis B infection by a 25-year universal vaccination program. J Hepatol. 2012;57(4):730–50. doi:10.1016/j.jhep.2012.05.021.
   PubMed Web of Science ®Google Scholar
• Luo JS, Wang F, Liu J, Shan ZZ, Pan H. Analysis of the monitoring results of HBsAb among healthy population in Qiandongnan prefecture of Guizhou in 2013–2016. Stud Trace Elem Health. 2019;36(1):51–52+55.
   Google Scholar
• Yue X, Ge C, Zhuge S, He H, Yang H, Xu H, Huang A, Zhao Y. Changes and analysis of anti-HBs titres after primary immunization in 1- to 16-year-old Chinese children: a hospital-based study. J Viral Hepat. 2018;25(4):373–80. doi:10.1111/jvh.12818.
   PubMed Web of Science ®Google Scholar
• Shen LZ. Study on enhancing immunity of hepatitis B vaccine in children aged 5–16 years. Ningbo, China: Ningbo University; 2012. p. 1–69.
   Google Scholar
• Qian YH, Lin YD, Shen HB, Dong MH, Deng Y, Wang XW, Yang YQ, Gu J, Yu RB. Effects of vaccination on hepatitis B virus infection in adults. Chin J Prev Med. 2008;42(12):930–31.
   Google Scholar
• Lin B, Zeng KF, Xue L. Survey on adult HBV infection rate and influence factor in Karamay City. Pract Prev Med. 2006;13(5):1195–97.
   Google Scholar
• Peng SH, Liao Z, Xiong CH, Wen HR, Zhang YX, Zhao HB. Epidemic trend and clustering analysis of hepatitis B incidence rate in Nanchang City, 2004–2010. Chin J Dis Control Prev. 2012;16(1):43–45.
   Google Scholar
• Tang Y. Evaluation and study on the effect of 20μg hepatitis B vaccine inoculation strategy in the army. Academy of Military Sciences; 2018.
   Google Scholar
• Yang Q, Chen XC, Tong WB, Liu Y, Bao Y, Qi Q. Hepatitis B surface antibody levels among healthy people in Sichuan province, 2018. Chin J Vaccines Immunization. 2019;25(5):524–27.
   Google Scholar
• Wang JH, Wang W, Sun L, Liang Y, Liu Y, Du H, Zhang ZG, Guo Y. Analysis of the antibody level for the hepatitis B surface antigen of the healthy population in Hebei province from 2008 to 2010. Chin J Health Lab Technol. 2011;21(9):2275–76.
   Google Scholar
• Deng QY, Zhong G, Wei JH, Yang RC, Du ZQ, Dong AH. Serological survey of hepatitis B and coverage of hepatitis B vaccine among people aged 1–29 years in Guangxi Zhuang Autonomous Region, 2014. Chin J Vaccines Immunization. 2017;23(4):406–10.
   Google Scholar
• He XT, Ma SH, Fan CX, Dong DW, Bao M. Investigation of hepatitis B KAP among 4 college students in Guangzhou. Chin J School Health. 2010;31(3):276–78.
   Google Scholar
• Tan XH. Investigation and analysis of hepatitis B infection among college students and countermeasures of health education. Chin Foreign Med Treat. 2010;1:149–50.
   Google Scholar
• Zhang SX, Sun PP, Xia Y. Evaluation and forecast for economic outcomes of hepatitis B immunoprophylaxis strategies in China from 2006 to 2030. Chin J Dis Control Prev. 2018;22:741–46.
   Google Scholar
• Li Y. Distribution characteristics of HBS Ag in high and low incidence areas of hepatitis B in China. Henan J Prev Med. 1983;3:1–5+26.
   Google Scholar
• Sha QH. Epidemiological investigation of viral hepatitis in Guangdong province. Vol. 2. Guangzhou,China: Epidemic Control Data of Guangdong; 1981. p. 32–39.
   Google Scholar
• Chung PW, Suen SH, Chan OK, Lao TH, Leung TY. Awareness and knowledge of hepatitis B infection and prevention and the use of hepatitis B vaccination in the Hong Kong adult Chinese population. Chin Med J (Engl). 2012;125:422–27.
   PubMed Web of Science ®Google Scholar
• Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383–403. doi:10.1016/S2468-1253(18)30056-6.
   PubMed Web of Science ®Google Scholar
• Liu MH, Sheng YJ, Liu JY, Hu H-D, Zhang Q-F, Ren H. Efficacy of telbivudine on interruption of hepatitis B virus vertical transmission: a meta-analysis. Ann Saudi Med. 2013;33(2):169–76. doi:10.5144/0256-4947.2013.169.
   PubMed Web of Science ®Google Scholar
• Lao TT, Sahota DS, Chan PKS. Three decades of neonatal vaccination has greatly reduced antenatal prevalence of hepatitis B virus infection among gravidae covered by the program. J Infect. 2018;76(6):543–49. doi:10.1016/j.jinf.2018.04.003.
   PubMed Web of Science ®Google Scholar
• Zhang W, Lin CY, Han LL, Li LQ, Gao P, Lin H, Gong XH, Huang F, Tang YQ, Ma JX, et al. Study on immune effects and influencing factors of different doses of domestic recombinant yeast hepatitis B vaccine in adults. Chin J Epidemiol. 2010;31(7):767–70.
   Google Scholar
• Wang ZZ, Gao YH, Wang P, Wei L, Xie C-P, Yang Z-X, Lan J, Fang Z-L, Zeng Y, Yan L, et al. Comparison of immunogenicity between hepatitis B vaccines with different dosages and schedules among healthy young adults in China: a 2-year follow-up study. Hum Vaccin Immunother. 2018;14(6):1475–82. doi:10.1080/21645515.2018.1438090.
   PubMed Web of Science ®Google Scholar
• Pei G, Xu JM, Zhang B, Gui XF. Analysis on the epidemiology of hepatitis B in Shishou City, 2004–2010. Chin J Dis Control Prev. 2012;16(3):226–29.
   Google Scholar
• Ye LX, Zhou DJ, Yang JJ, Tang SW, Li XT, Yi YC. Immune effect of recombinant yeast hepatitis B vaccine in adults. Chin J Epidemiol. 2003;24(10):953–54.
   Google Scholar
• Cassidy WM, Watson B, Ioli VA, Williams K, Bird S, West DJ. A randomized trial of alternative two-and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory. Pediatrics. 2001;107:626–31. doi:10.1542/peds.107.4.626.
   PubMed Web of Science ®Google Scholar
• National Health and Family Planning Commission; National Development and Reform Commission; Ministry of Education; Ministry of Science and Technology; Ministry of Industry and Information Technology; The Ministry of Oublic Securuty; The Ministry of Finance; Ministry of Human Resourcs and Social Security; Ministry of Housing ang Urban-Rural Development; China Food and Drug Administration; National Administration of Traditional Chinese Medicine(NATCM). Action plan for the prevention and treatment of viral hepatitis in China (2017–2020). Chin J Viral Dis. 2018;8(1):1–5.
   Google Scholar